EPIC CLINICAL TRIAL: PSEUDOMONAS AERUGINOSA AIRWAY INFECTION IN YOUNG CF PATIEN

史诗般的临床试验：年轻 CF 患者的铜绿假单胞菌气道感染

• 批准号: 7377531
• 负责人: George Z Retsch-Bogart
• 金额: $ 0.15万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377531
• 关键词: EPIC; CLINICAL; TRIAL; PSEUDOMONAS; AERUGINOSA

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this study is to find the best, safety and shortest treatment against FA that will kill the Pa bacteria and have the best immediate and longterm benefits for children with CF.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。这项研究的目的是找到最好的，安全的和最短的治疗FA，将杀死PA细菌，并有最好的直接和长期的好处，儿童CF。